Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 28 $ 60
Prepaid expenses 246 30
Total Current Assets 274 90
Intangible assets 0 25,262
Operating lease right-to use asset 110 0
Deposits 12 12
Fixed assets, net 0 35
Total Other Assets 122 25,309
TOTAL ASSETS 396 25,399
Current Liabilities:    
Accounts payable 1,940 1,762
Accrued expenses 2,379 1,023
Accrued interest 2,029 432
Line of credit 31 31
Note Payable to Related Party 0 100
Deferred Rent 0 8
Operating lease liability 120 0
Convertible debentures 13,207 10,673
Total Current Liabilities 19,706 14,029
Total liabilities 19,706 14,029
Commitments and contingencies
Stockholders' (Deficit) Equity:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 69784699 and 50,650,478 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively 70 51
Additional paid-in capital 548,118 540,171
Accumulated deficit (567,332) (528,685)
Noncontrolling interest (169) (169)
Total Stockholders' (deficit) Equity (19,310) 11,370
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 396 25,399
Series C    
Stockholders' (Deficit) Equity:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized 1 1
Series J    
Stockholders' (Deficit) Equity:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized $ 2 $ 1